miRoncol Health Launches AI Cancer Screening Blood Test in Ontario
miRoncol Health announced in a press release the launch of miCheckup, a miRNA blood test for multi cancer screening in Ontario. The service is available to eligible adults who have no cancer symptoms and costs CAD $1,299.
The test profiles microRNA molecules in a blood sample, then uses an AI algorithm to identify patterns associated with cancer. Customers request the test through a private virtual clinic, receive a requisition from a qualified practitioner when appropriate, and provide a blood sample at LifeLabs.
If the test detects a suspected cancer signal, the price covers a private whole body MRI when the scan is suitable and available through a participating facility. The company says a positive signal is not a cancer diagnosis, and customers should continue recommended screening and medical care regardless of the result.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 1 TransPerfect Acquires Synterex for AI Assisted Medical Writing Oct 1 Glintt Life Wins Silver Award for Pharmacy Visual Support Oct 1 Verana Health Adds AI Tools and Ophthalmology Datasets Oct 1 Codoxo Named to TIME's 2026 Health Tech Ranking Oct 1 Hansa Biopharma Partners With Cradle on AI Protein DesignLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
QC Healthcare Partners With Sanguina for AI Blood Health Screening
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
NYU Langone AI Uses Multiple 3D Mammograms to Predict Breast Cancer Risk
Milliman MedInsight Introduces MIKE for Healthcare Analytics
Daily AI Brief: the AI news that matters, in your inbox.